Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
June 18, 2018
Caelum Biosciences Announces Presentation of Complete Cardiac Data Analysis from Phase 1b Trial of CAEL-101 in AL Amyloidosis at American Society of Echocardiography 29th Annual Scientific Sessions
NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (FBIO) Company developing treatments for rare and life-threatening diseases, ...
June 18, 2018
PolarityTE Provides Corporate Update on Company Progress
SALT LAKE CITY, June 18, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of ...
June 18, 2018
Albireo Appoints Jason G. Duncan as General Counsel and Secretary
BOSTON, June 18, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
June 18, 2018
Oncobiologics Announces Randy Thurman as Executive Chairman of the Board of Directors and Lawrence A. Kenyon as Interim CEO
CRANBURY, N.J., June 18, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) today announced that Pankaj Mohan, Ph.D., its Chairman and Chief Executive Officer (CEO), has ...
June 14, 2018
ProQR to Present at the JMP Life Sciences Conference
LEIDEN, the Netherlands, June 14, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of transformative RNA ...
June 14, 2018
Aptose Enters Into License Agreement With CrystalGenomics to Acquire CG-806 Rights in China
SAN DIEGO and SEOUL, South Korea, June 14, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO) today announced that they have entered into a ...
June 14, 2018
Foamix Pharmaceuticals to Participate in the Cantor Dermatology & Aesthetics Summit
REHOVOT, Israel and BRIDGEWATER, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), a clinical stage specialty pharmaceutical company focused on developing and ...
June 14, 2018
AIT Therapeutics Reports Financial Results for Three Months Ended March 31, 2018
NEW YORK, June 14, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the ...
June 14, 2018
Reata Pharmaceuticals, Inc. Secures $125 Million Term Loan Facility
IRVING, Texas, June 14, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced that it entered ...
June 14, 2018
Pfenex to Present at the JMP Securities 2018 Life Science Conference
SAN DIEGO, June 14, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX) announced today that it will be presenting at the JMP Securities 2018 Life ...
June 13, 2018
TRACON Announces Presentation of Preclinical Data from Studies of TRC105 in Combination with a PD-1 Antibody in Murine Models of Colorectal Cancer
SAN DIEGO, June 13, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
June 13, 2018
UroGen Pharma’s Chairman, Arie Belldegrun, MD, FACS to Receive EY 2018 Master Entrepreneur Award
RA’ANANA, Israel and NEW YORK, June 13, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
June 13, 2018
Vermillion Names Chris Goulart to Senior Vice President of Commercial Operations
AUSTIN, Texas, June 13, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that Mr. Chris Goulart ...
June 13, 2018
OSE Immunotherapeutics Announces Results of 2018 Annual Shareholder Meeting
NANTES, France, June 13, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA(ISIN:FR0012127173) (Mnémo:OSE) announces that all the resolutions submitted to a vote at the Combined General ...
June 12, 2018
Kuros Biosciences Announces Start of Randomized Controlled Trial of MagnetOs in Spinal Fusion
SCHLIEREN (ZURICH), Switzerland, June 12, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) announced today that the University Medical Center Utrecht (UMCU) in the Netherlands has ...
June 12, 2018
Galmed's 600 mg Aramchol™ Achieved a Regulatory Approvable Endpoint Showing NASH Resolution Without Worsening of Fibrosis, in NASH Patients, in the Global Phase 2b ARREST 52-Week Study
Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of Aramchol™, an oral, once-daily, liver-targeted SCD1 modulator, for ...
June 12, 2018
ProQR Receives up to $5 Million in Partnership with EB Research Partnership and EB Medical Research Foundation to Develop QR-313 for the Treatment of Dystrophic Epidermolysis Bullosa
LEIDEN, the Netherlands, June 12, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of transformative RNA ...
June 12, 2018
CytoSorbents Officially Opens New U.S. CytoSorb Manufacturing Facility
MONMOUTH JUNCTION, N.J., June 12, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation ...
June 12, 2018
Bellerophon Therapeutics to Participate on Panel at JMP Securities Life Sciences Conference
WARREN, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that it will ...
June 12, 2018
Tyme Releases Detailed Data and Analyses with SM-88 From the First Human Study and Compassionate Use Programs
NEW YORK, June 12, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), a clinical-stage biotechnology company developing cancer therapeutics, today release detailed patient data and ...
Page 84 of 169